Oestrogens combined with progestogens
Drug Safety Update
September 2019: Hormone replacement therapy (HRT): further information on the known increased risk of breast cancer with HRT and its persistence after stopping
December 2014: Hormone Replacement Therapy - updated advice before prescribing HRT healthcare professionals should carefully consider the potential benefit and risks for every woman
Local guidance
See here for K&M HRT Prescribing Guideline
NICE Guidance
NG23: Menopause: identification and management
This is a continuous combined HRT
| Pack |
|---|
| 12 patch |
| 4 patch |
This is a continuous combined HRT
| Pack |
|---|
| 24 patch |
| 4 patch |
| 8 patch |
| Pack |
|---|
| 84 tablet (3 x 28 tablets) |
| Pack |
|---|
| 84 tablet (3 x 28 tablets) |
| Pack |
|---|
| 84 tablet (3 x 28 tablets) |
This is a continuous combined HRT
| Pack |
|---|
| 84 tablet (3 x 28 tablets) |
| Pack |
|---|
| 84 tablet (3 x 28 tablets) |
This is a sequential combined HRT
| Pack |
|---|
| 8 patch (4 patches + 4 patches) |
This is a sequential combined HRT
| Pack |
|---|
| 84 tablet (3 x (14 tablets + 14 tablets)) |
| Pack |
|---|
| 84 tablet (3 x (14 tablets + 14 tablets)) |
This is a sequential combined HRT
| Pack |
|---|
| 84 tablet (3 x (16 tablets + 12 tablets )) |
| Pack |
|---|
| 84 tablet (3 x (16 tablets + 12 tablets )) |
| Pack |
|---|
| 84 tablet (3 x (16 tablets + 12 tablets)) |
This is a continuous combined HRT
| Pack |
|---|
| 28 capsule (2 x 14 capsules) |
| 84 capsule (6 x 14 capsules) |
| Pack |
|---|
| 8 patch |
| 24 patch |
| Pack |
|---|
| 8 patch |
| 24 patch |
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary